- Home
- UTHR vs SFM Comparison
UTHR vs SFM Comparison
Compare UTHR & SFM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UTHR
- SFM
- Stock Information
- Founded
- UTHR 1996
- SFM 2002
- Country
- UTHR United States
- SFM United States
- Employees
- UTHR N/A
- SFM N/A
- Industry
- UTHR Biotechnology: Pharmaceutical Preparations
- SFM Food Chains
- Sector
- UTHR Health Care
- SFM Consumer Staples
- Exchange
- UTHR Nasdaq
- SFM Nasdaq
- Market Cap
- UTHR 20.7B
- SFM 10.9B
- IPO Year
- UTHR 1999
- SFM 2013
- Fundamental
- Price
- UTHR $470.12
- SFM $81.96
- Analyst Decision
- UTHR Buy
- SFM Buy
- Analyst Count
- UTHR 12
- SFM 14
- Target Price
- UTHR $495.08
- SFM $138.64
- AVG Volume (30 Days)
- UTHR 568.9K
- SFM 3.4M
- Earning Date
- UTHR 10-29-2025
- SFM 10-29-2025
- Dividend Yield
- UTHR N/A
- SFM N/A
- EPS Growth
- UTHR 16.08
- SFM 49.03
- EPS
- UTHR 26.38
- SFM 5.15
- Revenue
- UTHR $3,128,400,000.00
- SFM $8,653,696,000.00
- Revenue This Year
- UTHR $13.68
- SFM $15.50
- Revenue Next Year
- UTHR $5.63
- SFM $10.24
- P/E Ratio
- UTHR $17.68
- SFM $15.88
- Revenue Growth
- UTHR 13.50
- SFM 16.60
- 52 Week Low
- UTHR $266.98
- SFM $75.75
- 52 Week High
- UTHR $479.50
- SFM $182.00
- Technical
- Relative Strength Index (RSI)
- UTHR 67.39
- SFM 32.37
- Support Level
- UTHR $444.04
- SFM $77.87
- Resistance Level
- UTHR $464.27
- SFM $82.53
- Average True Range (ATR)
- UTHR 15.76
- SFM 3.47
- MACD
- UTHR 1.66
- SFM 0.22
- Stochastic Oscillator
- UTHR 84.40
- SFM 19.93
About UTHR United Therapeutics Corporation
United Therapeutics Corp specializes in drug development for pulmonary arterial hypertension (PAH), a rare and progressive disease marked by abnormally high blood pressure in the arteries of the lungs. The company's therapies for PAH largely focus on the prostacyclin pathway, and many of its treatments are based on the same molecule, treprostinil. The company markets and sells the following commercial therapies in the United States to treat PAH: Tyvaso DPI (treprostinil) Inhalation Powder, Remodulin Injection, Orenitram (treprostinil) Extended-Release Tablets, Adcirca (tadalafil) Tablets, and Unituxin. In addition, it is developing a pipeline of projects that includes new indications and delivery devices for existing products and new products to treat PAH and other conditions.
About SFM Sprouts Farmers Market Inc.
Sprouts Farmers Market Inc offers a specialty grocery experience featuring an open layout with fresh produce at the heart of the store. Sprouts inspire wellness naturally with a carefully curated assortment products paired with purpose-driven people. The company continues to bring products made with lifestyle-friendly ingredients such as organic, plant-based, and gluten-free. It approximately has 407 stores in nearly 23 states. The Company has one operating segment that is healthy grocery stores.